Tildacerfont
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Product Specifications
CAS Number
[1014983-00-6]
Product Name Alternative
SPR001; LY2371712
UNSPSC
12352005
Target
CRFR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tildacerfont.html
Purity
98.60
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
CCC(CC)C1=CC(C)=NC2=C(C(C)=NN12)C3=C(N=C(S3)N4CCOCC4)Cl
Molecular Formula
C20H26ClN5OS
Molecular Weight
419.97
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CRFR1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PIGO (GPI Ethanolamine Phosphate Transferase 3, Phosphatidylinositol-glycan Biosynthesis Class O Protein, PIG-O, UNQ632/PRO1249, DKFZp434M222, FLJ00135, MGC20536, MGC3079, RP11-182N22.4) (AP)
PIGO (GPI Ethanolamine Phosphate Transferase 3, Phosphatidylinositol-glycan Biosynthesis Class O Protein, PIG-O, UNQ632/PRO1249, DKFZp434M222, FLJ00135, MGC20536, MGC3079, RP11-182N22.4) (AP)
